Back to trial details

Intake questionnaire

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Applying to University of Chicago - Medical Center · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you between 18 and 75 years old?
2. Have you been diagnosed with Amyloidosis?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Chicago for study visits?